Tadalafil Lilly

Nazione: Unione Europea

Lingua: inglese

Fonte: EMA (European Medicines Agency)

Compra

Foglio illustrativo Foglio illustrativo (PIL)
21-09-2023
Scheda tecnica Scheda tecnica (SPC)
21-09-2023

Principio attivo:

tadalafil

Commercializzato da:

Eli Lilly Nederland B.V.

Codice ATC:

G04BE08

INN (Nome Internazionale):

tadalafil

Gruppo terapeutico:

Urologicals

Area terapeutica:

Erectile Dysfunction

Indicazioni terapeutiche:

Treatment of erectile dysfunction in adult males.In order for tadalafil to be effective, sexual stimulation is required.Tadalafil Lilly is not indicated for use by women.Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.

Dettagli prodotto:

Revision: 6

Stato dell'autorizzazione:

Authorised

Data dell'autorizzazione:

2017-03-22

Foglio illustrativo

                                61
B. PACKAGE LEAFLET
62
PACKAGE LEAFLET: INFORMATION FOR THE USER
TADALAFIL LILLY 2.5 MG FILM-COATED TABLETS
tadalafil
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Tadalafil Lilly is and what it is used for
2.
What you need to know before you take Tadalafil Lilly
3.
How to take Tadalafil Lilly
4.
Possible side effects
5
How to store Tadalafil Lilly
6.
Contents of the pack and other information
1.
WHAT TADALAFIL LILLY IS AND WHAT IT IS USED FOR
Tadalafil Lilly is a treatment for adult men with erectile
dysfunction. This is when a man cannot get,
or keep a hard, erect penis suitable for sexual activity. Tadalafil
Lilly has been shown to significantly
improve the ability of obtaining a hard erect penis suitable for
sexual activity.
Tadalafil Lilly contains the active substance tadalafil which belongs
to a group of medicines called
phosphodiesterase type 5 inhibitors. Following sexual stimulation
Tadalafil Lilly works by helping the
blood vessels in your penis to relax, allowing the flow of blood into
your penis. The result of this is
improved erectile function. Tadalafil Lilly will not help you if you
do not have erectile dysfunction.
It is important to note that Tadalafil Lilly does not work if there is
no sexual stimulation. You and your
partner will need to engage in foreplay, just as you would if you were
not taking a medicine for
erectile dysfunction.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE TADALAFIL LILLY
DO NOT TAKE TADALAFIL LILLY IF YOU:
-
are allergic to tadalafil or any of the othe
                                
                                Leggi il documento completo
                                
                            

Scheda tecnica

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Tadalafil Lilly 2.5 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ _
Each tablet contains 2.5 mg tadalafil.
Excipient with known effect
Each coated tablet contains 87 mg of lactose (as monohydrate).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet).
Light orange-yellow and almond shaped tablets of 8.58 mm by 5.23 mm,
marked "C 2 ½" on one side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of erectile dysfunction in adult males.
In order for tadalafil to be effective, sexual stimulation is
required.
Tadalafil Lilly is not indicated for use by women.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adult men _
In general, the recommended dose is 10 mg taken prior to anticipated
sexual activity and with or
without food.
In those patients in whom tadalafil 10 mg does not produce an adequate
effect, 20 mg might be tried. It
may be taken at least 30 minutes prior to sexual activity.
The maximum dose frequency is once per day.
Tadalafil 10 and 20 mg is intended for use prior to anticipated sexual
activity and it is not
recommended for continuous daily use.
In patients who anticipate a frequent use of Tadalafil Lilly (i.e., at
least twice weekly) a once daily
regimen with the lowest doses of Tadalafil Lilly might be considered
suitable, based on patient choice
and the physician’s judgement.
In these patients the recommended dose is 5 mg taken once a day at
approximately the same time of
day. The dose may be decreased to 2.5 mg once a day based on
individual tolerability.
The appropriateness of continued use of the daily regimen should be
reassessed periodically.
3
_Special populations _
_Elderly men _
Dose adjustments are not required in elderly patients.
_Men with renal impairment _
Dose adjustments are not required in patients with mild to moderate
renal impairment. For patients
with severe renal impairment 10 mg is the maximum recommended dose.

                                
                                Leggi il documento completo
                                
                            

Documenti in altre lingue

Foglio illustrativo Foglio illustrativo bulgaro 21-09-2023
Scheda tecnica Scheda tecnica bulgaro 21-09-2023
Foglio illustrativo Foglio illustrativo spagnolo 21-09-2023
Scheda tecnica Scheda tecnica spagnolo 21-09-2023
Relazione pubblica di valutazione Relazione pubblica di valutazione spagnolo 07-04-2017
Foglio illustrativo Foglio illustrativo ceco 21-09-2023
Scheda tecnica Scheda tecnica ceco 21-09-2023
Foglio illustrativo Foglio illustrativo danese 21-09-2023
Scheda tecnica Scheda tecnica danese 21-09-2023
Foglio illustrativo Foglio illustrativo tedesco 21-09-2023
Scheda tecnica Scheda tecnica tedesco 21-09-2023
Foglio illustrativo Foglio illustrativo estone 21-09-2023
Scheda tecnica Scheda tecnica estone 21-09-2023
Foglio illustrativo Foglio illustrativo greco 21-09-2023
Scheda tecnica Scheda tecnica greco 21-09-2023
Foglio illustrativo Foglio illustrativo francese 21-09-2023
Scheda tecnica Scheda tecnica francese 21-09-2023
Relazione pubblica di valutazione Relazione pubblica di valutazione francese 07-04-2017
Foglio illustrativo Foglio illustrativo italiano 21-09-2023
Scheda tecnica Scheda tecnica italiano 21-09-2023
Relazione pubblica di valutazione Relazione pubblica di valutazione italiano 07-04-2017
Foglio illustrativo Foglio illustrativo lettone 21-09-2023
Scheda tecnica Scheda tecnica lettone 21-09-2023
Foglio illustrativo Foglio illustrativo lituano 21-09-2023
Scheda tecnica Scheda tecnica lituano 21-09-2023
Foglio illustrativo Foglio illustrativo ungherese 21-09-2023
Scheda tecnica Scheda tecnica ungherese 21-09-2023
Relazione pubblica di valutazione Relazione pubblica di valutazione ungherese 07-04-2017
Foglio illustrativo Foglio illustrativo maltese 21-09-2023
Scheda tecnica Scheda tecnica maltese 21-09-2023
Foglio illustrativo Foglio illustrativo olandese 21-09-2023
Scheda tecnica Scheda tecnica olandese 21-09-2023
Relazione pubblica di valutazione Relazione pubblica di valutazione olandese 07-04-2017
Foglio illustrativo Foglio illustrativo polacco 21-09-2023
Scheda tecnica Scheda tecnica polacco 21-09-2023
Foglio illustrativo Foglio illustrativo portoghese 21-09-2023
Scheda tecnica Scheda tecnica portoghese 21-09-2023
Relazione pubblica di valutazione Relazione pubblica di valutazione portoghese 07-04-2017
Foglio illustrativo Foglio illustrativo rumeno 21-09-2023
Scheda tecnica Scheda tecnica rumeno 21-09-2023
Foglio illustrativo Foglio illustrativo slovacco 21-09-2023
Scheda tecnica Scheda tecnica slovacco 21-09-2023
Relazione pubblica di valutazione Relazione pubblica di valutazione slovacco 07-04-2017
Foglio illustrativo Foglio illustrativo sloveno 21-09-2023
Scheda tecnica Scheda tecnica sloveno 21-09-2023
Foglio illustrativo Foglio illustrativo finlandese 21-09-2023
Scheda tecnica Scheda tecnica finlandese 21-09-2023
Relazione pubblica di valutazione Relazione pubblica di valutazione finlandese 07-04-2017
Foglio illustrativo Foglio illustrativo svedese 21-09-2023
Scheda tecnica Scheda tecnica svedese 21-09-2023
Foglio illustrativo Foglio illustrativo norvegese 21-09-2023
Scheda tecnica Scheda tecnica norvegese 21-09-2023
Foglio illustrativo Foglio illustrativo islandese 21-09-2023
Scheda tecnica Scheda tecnica islandese 21-09-2023
Foglio illustrativo Foglio illustrativo croato 21-09-2023
Scheda tecnica Scheda tecnica croato 21-09-2023

Cerca alert relativi a questo prodotto

Visualizza cronologia documenti